BioStock Studio: Cereno Scientific’s CEO about expanded portfolio and upcoming phase II
Last week, Spotlight-listed Cereno Scientific published its report for the first quarter. The company’s CEO Sten R Sörensen, visited BioStock’s studio and talked about the preparations for the upcoming phase II trial, and how their international network and collaborations have resulted in two preclinical development programmes, and what awaits the company in the near term. Watch the full interview in Swedish below.
Watch the full interview with Cereno Scientific's CEO Sten R Sörensen at biostock.se:
This is a press release from BioStock - Connecting Innovation &Capital. https://www.biostock.se/